Search research articles
Contact Us
Filters
Showing results (231-240 of 270) with videos related to
Page
of 27
Sort By:
Bone Marrow Transplantation
|
December 8, 2015
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
M C Oliveira, M Labopin, J Henes, et al.
Leukemia
|
August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry
M Michallet, M Sobh, D Milligan, et al.
Bone Marrow Transplantation
|
August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)
A R Zander, N Kröger, M Schleuning, et al.
Bone Marrow Transplantation
|
February 9, 2016
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
F Heinzelmann, W Bethge, D W Beelen, et al.
Bone Marrow Transplantation
|
June 2, 2016
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
M C Oliveira, M Labopin, J Henes, et al.
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
S K Metzelder, T Schroeder, M Lübbert, et al.
Leukemia
|
June 1, 2017
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
B Kasenda, G Ihorst, R Schroers, et al.
Bone Marrow Transplantation
|
December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party
S P Robinson, A Boumendil, H Finel, et al.
Bone Marrow Transplantation
|
November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis
R Saccardi, A Tyndall, G Coghlan, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 270) with videos related to
Sort By:
Page
of 27
Bone Marrow Transplantation
|
December 8, 2015
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
M C Oliveira, M Labopin, J Henes, et al.
Leukemia
|
August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry
M Michallet, M Sobh, D Milligan, et al.
Bone Marrow Transplantation
|
August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)
A R Zander, N Kröger, M Schleuning, et al.
Bone Marrow Transplantation
|
February 9, 2016
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
F Heinzelmann, W Bethge, D W Beelen, et al.
Bone Marrow Transplantation
|
June 2, 2016
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
M C Oliveira, M Labopin, J Henes, et al.
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
S K Metzelder, T Schroeder, M Lübbert, et al.
Leukemia
|
June 1, 2017
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group
B Kasenda, G Ihorst, R Schroers, et al.
Bone Marrow Transplantation
|
December 1, 2015
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party
S P Robinson, A Boumendil, H Finel, et al.
Bone Marrow Transplantation
|
November 2, 2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis
R Saccardi, A Tyndall, G Coghlan, et al.
Page
of 27